Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 365 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obsessive Compulsive Disorder (OCD) Clear all

Conditions: Well-Being, Psychological, Mood Disturbance, Emotional Regulation, Dissociation, Post Traumatic Stress Symptoms
Interventions: Neuroptimal (Zengar, Inc.) Neurofeedback; Device
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Obsessive-compulsive Disorder
Interventions: Propanolol, Placebo; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Obsessive-Compulsive Disorder
Interventions: Paliperidone, Placebo; Drug
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 70 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 2
States / cities: St. Petersburg, Florida • Indianapolis, Indiana

Conditions: Obsessive-Compulsive Disorder, Body Dysmorphic Disorders, Illness Anxiety Disorder
Interventions: Caloric Vestibular Stimulation; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Impulse Control Disorders
Interventions: Sertraline, Habit Reversal Training; Drug · Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2004
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Anxiety, Obsessive-Compulsive Disorder
Interventions: VR System, Control; Other
Lead sponsor: Minnesota HealthSolutions; Industry
Eligibility: 7 Years to 17 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Autism Spectrum Disorders, Autism, Asperger's Syndrome, Pervasive Developmental Disability - Not Otherwise Specified, Obsessive-compulsive Disorder, Social Phobia, Generalized Anxiety Disorder, Specific Phobia, Separation Anxiety Disorder
Interventions: Personalized Cognitive-behavioral therapy, Standard Practice Cognitive-behavioral therapy, Treatment as Usual; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 7 Years to 13 Years
Enrollment: 214 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Trichotillomania
Interventions: Keen2 Predictive Awareness Bracelet; Behavioral
Lead sponsor: HabitAware Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Kent, Ohio

Conditions: Obsessive-Compulsive Disorder
Interventions: Cognitive Bias Modification; Other
Lead sponsor: University of Wisconsin, Milwaukee; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Anxiety, Anxiety Acute, Anxiety Chronic, Anxiety and Mood Disorders, Social Anxiety Disorder, Panic Disorder (With or Without Agoraphobia), Generalized Anxiety Disorder, Obsessive-Compulsive Disorder, Specific Phobia
Interventions: Cognitive therapy, Behavioral therapy, Mindfulness-based therapy; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Obsessive-Compulsive Disorder
Interventions: D-Cycloserine, Placebo; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 7 Years to 17 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obsessive Compulsive Disorder
Interventions: NPL-2003; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: OCD
Interventions: Sertraline, No Intervention; Drug · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 8 Years to 17 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Obsessive-Compulsive Disorder
Interventions: Regular Titration, Placebo, Slow Titration; Drug
Lead sponsor: University of Florida; Other
Eligibility: 7 Years to 17 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Gainesville, Florida • Tampa, Florida

Conditions: Pathologic Skin Picking, Neurotic Excoriation, Psychogenic Excoriation, Dermatillomania
Interventions: N-Acetyl Cysteine, Placebo; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 64 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obsessive-Compulsive Disorder
Interventions: tDCS; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Obsessive Compulsive Disorder (OCD)
Interventions: Active transcranial direct current stimulation, Sham transcranial direct current stimulation; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Skin-Picking
Interventions: Computerized cognitive training; Behavioral
Lead sponsor: University of Wisconsin, Milwaukee; Other
Eligibility: 18 Years to 60 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Hoarding Disorder
Interventions: RECLAIM: Reducing Clutter and Increasing Meaning, Sorting Practice; Behavioral
Lead sponsor: Mississippi State University; Other
Eligibility: 60 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Starkville, Mississippi

Conditions: Obsessive-Compulsive Disorder
Interventions: Personalized Computer Program, Cognitive Behavioral Therapy; Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Obsessive-Compulsive Disorder
Interventions: Ketamine, Placebo; Drug
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Obsessive Compulsive Disorder
Interventions: Flumazenil; Drug
Lead sponsor: Parkway Medical Center; Other
Eligibility: 19 Years to 60 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obsessive Compulsive Disorder
Interventions: Cognitive Behavior Therapy, Relaxation Therapy; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 5 Years to 8 Years
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 3
States / cities: Durham, North Carolina • Philadelphia, Pennsylvania • Providence, Rhode Island

Conditions: Obsessive Compulsive Disorder
Interventions: Tasked based functional MRI (fMRI), Eye Tracking Device; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 60 Years
Enrollment: 308 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Neurofeedback and Well-Being Among People With Co-Occurring Obsessive Compulsive Disorder and Post-traumatic Stress Symptoms

Brief Intervention for OCD Fears

Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder

Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders

Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania

Virtual Reality System for Anxiety and OCD

Psychotherapy for Anxiety in Children With Autism Spectrum Disorder

Technology Assisted Treatment of Trichotillomania: Open Trial

Cognitive Bias Modification for Thought-Action Fusion

Anxiety Skills Study

The Use of D-Cycloserine to Augment CBT for Pediatric OCD

Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD)

Effects of Sertraline on Brain Connectivity in Adolescents With OCD

Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder

N-Acetyl Cysteine in Pathologic Skin Picking

Enhancement of Therapeutic Learning in OCD Using tDCS

Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder

Skin Picking Approach Avoidance Task

Motivational Interviewing to Enhance Behavioral Change in Older Adults With Hoarding Disorder

Personalized Computerized Inhibitory Control Training for OCD

A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder

A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder

Comparing the Effectiveness of Two Family-based Therapies in Treating Young Children With Obsessive-Compulsive Disorder

Neurobiology of Sensory Phenomena in Obsessive-Compulsive Disorder